Walter C. Olson - Concepedia

Author

Walter C. Olson

Also Known As

David Brenin, W C Olson, W Olson, W. C. OLSON, W. C. Olson, W. Olson, W.C. Olson, WALTER C. OLSON, WALTER OLSON, Walter C Olson

120

Publications

2.5K

Citations

H-Index

Concepts

All Affiliations

University of Virginia University of Pittsburgh UPMC Hillman Cancer Center University of Virginia Health System University of Pittsburgh Medical Center

About

Walter C. Olson is an author at University of Virginia specializing in immunology, medicine, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	20	995
2	Cell Biology	11	11	637
3	Natural Sciences	1	1	232
4	Public Health	1	1	17
5	Cellular Physiology	1	1	232

Walter C. Olson

Publications

2.4K

Citations

H-Index

Page 1

	Year	Citations
Light chain gene conversion continues at high rate in an ALV-induced cell line. J M Buerstedde, Claude–Agnès Reynaud, E H Humphries, The EMBO Journal High RateNatural SciencesGeneticsAlv-induced Cell LineMolecular Biology	1990	232
Effect of Granulocyte/Macrophage Colony-Stimulating Factor on Circulating CD8+ and CD4+ T-Cell Responses to a Multipeptide Melanoma Vaccine: Outcome of a Multicenter Randomized Trial Craig L. Slingluff, Gina R. Petroni, Walter C. Olson, Clinical Cancer Research	2009	168
Mature dendritic cells pulsed with freeze–thaw cell lysates define an effective in vitro vaccine designed to elicit EBV-specific CD4+ and CD8+ T lymphocyte responses Wolfgang Herr, Elena Ranieri, Walter C. Olson, Blood	2000	153
Disease stage variation in CD4+ and CD8+ T-cell reactivity to the receptor tyrosine kinase EphA2 in patients with renal cell carcinoma. Tomohide Tatsumi, Christopher J. Herrem, Walter C. Olson, PubMed Renal PathologyImmunologyPathologyImmunologic MechanismAntigen Processing	2003	141
Helper T-Cell Responses and Clinical Activity of a Melanoma Vaccine With Multiple Peptides From MAGE and Melanocytic Differentiation Antigens Craig L. Slingluff, Gina R. Petroni, Walter C. Olson, Journal of Clinical Oncology	2008	117
A Randomized Phase II Trial of Multiepitope Vaccination with Melanoma Peptides for Cytotoxic T Cells and Helper T Cells for Patients with Metastatic Melanoma (E1602) Craig L. Slingluff, Fengmin Zhao, Kimberly A. Chianese‐Bullock, Clinical Cancer Research	2013	115
A Multipeptide Vaccine is Safe and Elicits T-cell Responses in Participants With Advanced Stage Ovarian Cancer Kimberly A. Chianese‐Bullock, William P. Irvin, Gina R. Petroni, Journal of Immunotherapy	2008	110
Shipping blood to a central laboratory in multicenter clinical trials: effect of ambient temperature on specimen temperature, and effects of temperature on mononuclear cell yield, viability and immunologic function Walter C. Olson, Mark E. Smolkin, Erin M Farris, Journal of Translational Medicine	2011	91
Dendritic Cells Transduced with an Adenovirus Vector Encoding Epstein-Barr Virus Latent Membrane Protein 2B: a New Modality for Vaccination Elena Ranieri, W. Herr, Andrea Gambotto, Journal of Virology	1999	76
A pilot study of the immunogenicity of a 9-peptide breast cancer vaccine plus poly-ICLC in early stage breast cancer Patrick M. Dillon, Gina R. Petroni, Mark E. Smolkin, Journal for ImmunoTherapy of Cancer	2017	62

Page 1